About Biomaterials

Biomaterials are natural or synthetic materials that are engineered to interact safely and effectively with biological systems, primarily used in medical applications to support, enhance, or replace damaged tissue or biological functions. Biomaterials research at Cleveland State University takes an interdisciplinary approach to encompass areas such as tissue engineering, biomechanics, and nanomaterials. Ongoing research continues to expand the capabilities of biomaterials, integrating innovations such as nanotechnology, smart responsive polymers, and bioactive components to create more effective solutions.

Biomaterials Faculty

Dr. Nolan B Holland
Chair and Professor
(216)-687-2572
n.holland1@csuohio.edu 
Developing new stimuli-responsive materials that utilize thermoresponsive behavior for use as bio-inks for 3D bioprinting and as nanoparticles for targeted drug delivery. 
 

Dr. Chandra Kothapalli
Professor
(216)-687-2562
c.kothapalli@csuohio.edu
Development of extracellular matrix-based hydrogels and electrospun nanofibrous composites for neural, vascular, cardiac, skeletal muscle tissue engineering applications.
 

Dr. Chelsea Monty-Bromer
Associate Professor
(216)-687-9399
c.montybromer@csuohio.edu 
Development of electrochemical sensors to detect sweat biomarkers for real-time health monitoring.
 

Dr. Liqun Ning
Assistant Professor
(216)-687-2580
l.ning@csuohio.edu
Development of the next generation of tissue constructs, biomedical devices, and platforms for addressing significant challenges in regenerative medicine and disease modelling/drug screening.
 

Dr. Prabaha Sikder:
Assistant Professor
(216)-687-4687
p.sikder@csuohio.edu
Developing advanced technologies for tissue regeneration, including medical implants and scaffolds to treat orthopedic and musculoskeletal defects
 

Dr. Metin Uz:
Assistant Professor
(216)-687-3526
m.uz@csuohio.edu
Development of functional biomaterials-based biodegradable and implantable flexible/piezo electronic biointerfaces or conductive platforms for stem cell-based therapies targeting tissue regeneration with an emphasis on central/peripheral nervous system problems.